Inventor · disambiguated record
Michael Detmar
Also filed as: DETMAR MICHAEL · DETMAR MICHAEL J
12 granted patents·12 pending applications·42 citations·filing 2000–2022
86Inventor score
Top patents by PatentIndex Score
24 records- 0186US6712617B2Methods of preventing UVB-induced skin damageGEN HOSPITAL CORP·Filed 2002·Granted Mar 30, 2004·30 cites·17 claims
- 0274US6596276B1Method for inhibiting tumor angiogenesis in a living subjectBETH ISRAEL HOSPITAL·Filed 2000·Granted Jul 22, 2003·4 cites·7 claims
- 0370US6773881B2Methods of modulating hair growthGEN HOSPITAL CORP·Filed 2001·Granted Aug 10, 2004·7 cites·26 claims
- 0469US11992467B2Promotion of lymphatic functionUNIV BASEL·Filed 2022·Granted May 28, 2024·0 cites·7 claims
- 0564US8865673B2Monitoring and modulating HGF/HGFR activityDETMAR MICHAEL·Filed 2012·Granted Oct 21, 2014·1 cites·16 claims
- 0663US10718782B2Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicatorSHISEIDO CO LTD·Filed 2018·Granted Jul 21, 2020·0 cites·10 claims
- 0762US2020147004A1Promotion of lymphatic functionUNIV BASEL·Filed 2020·Application pending·0 cites
- 0861US2005171016A1Thrombospondin-2 and uses thereofGEN HOSPITAL CORP·Filed 2004·Application pending·0 cites
- 0959US2015030611A1Monitoring and Modulating HGF/HGFR ActivityGEN HOSPITAL CORP·Filed 2014·Application pending·0 cites
- 1056US11896707B2Cosmetic preparations comprising Daphne extractsETH ZUERICH·Filed 2019·Granted Feb 13, 2024·0 cites·18 claims
- 1156US2008176851A1Method for inhibiting lymphangiogenesis and inflammationSHISEIDO CO LTD·Filed 2007·Application pending·0 cites
- 1255US9933436B2Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicatorYOSHIDA YUZO·Filed 2012·Granted Apr 3, 2018·0 cites·10 claims
- 1355US8367609B2Methods of reducing skin damage and edemaGEN HOSPITAL CORP·Filed 2007·Granted Feb 5, 2013·0 cites·20 claims
- 1452US9192652B2Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damageGEN HOSPITAL CORP·Filed 2013·Granted Nov 24, 2015·0 cites·17 claims
- 1550US2002119921A1Thrombospondin-2 and uses thereofFiled 2001·Application pending·0 cites
- 1650US2007010443A1Monitoring and modulating HGF/HGFR activityDETMAR MICHAEL·Filed 2006·Application pending·0 cites
- 1749US11390666B2Vascular endothelial growth factor/anti-fibronectin antibody fusion proteinsPHILOGEN SPA·Filed 2018·Granted Jul 19, 2022·0 cites·4 claims
- 1849US2010227821A1Monitoring and modulating hgf/hgfr activityGEN HOSPITAL CORP·Filed 2010·Application pending·0 cites
- 1949US2022257501A1Cosmetic Preparations Comprising Natural ActivatorsETH ZUERICH·Filed 2020·Application pending·0 cites
- 2049US2016367499A1Promotion of lymphatic functionETH ZUERICH·Filed 2015·Application pending·0 cites
- 2146US2002022592A1Delivery of thrombospondin from implantable tissue matricesFiled 2001·Application pending·0 cites
- 2242US11007282B2Compositions for circulatory system visualizationDICRONIS SAGL·Filed 2016·Granted May 18, 2021·0 cites·7 claims
- 2342US2005281761A1Methods of preventing UVB-induced skin damageDETMAR MICHAEL·Filed 2005·Application pending·0 cites
- 2435US2005250799A1Protease inhibitors for treatment of wrinklesFUJII SEISHIRO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Detmar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →